Stuttgart, Germany

Florian Von Der Mülbe

USPTO Granted Patents = 20 

 

Average Co-Inventor Count = 3.8

ph-index = 15

Forward Citations = 781(Granted Patents)


Location History:

  • Tubingen, DE (2012)
  • Tübingen, DE (2019)
  • Stuttgart, DE (2013 - 2023)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: Florian Von Der Mulbe: Innovator in mRNA Therapeutics

Introduction

Florian Von Der Mulbe is a prominent inventor based in Stuttgart, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of mRNA-based therapeutics. With a total of three patents to his name, his work is paving the way for innovative cancer treatments.

Latest Patents

One of his latest patents is focused on the application of mRNA for use as a therapeutic against tumor diseases. This invention relates to a pharmaceutical composition that includes at least one mRNA coding for an antigen from a tumor, combined with an aqueous solvent and preferably a cytokine, such as GM-CSF. This composition is particularly aimed at therapy and prophylaxis against cancer. Another notable patent is a method for purifying RNA on a preparative scale using HPLC. This method is distinguished by the use of a porous reversed phase as the stationary phase for RNA purification.

Career Highlights

Florian is currently associated with CureVac GmbH, a company known for its pioneering work in mRNA technology. His role at CureVac has allowed him to be at the forefront of research and development in this rapidly evolving field.

Collaborations

He has collaborated with notable colleagues such as Ingmar Hoerr and Steve Pascolo, who are also recognized for their contributions to mRNA research.

Conclusion

Florian Von Der Mulbe's innovative work in mRNA therapeutics is making a significant impact in the fight against cancer. His patents reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…